Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Hypofractionated Conformal Radiotherapy with Concurrent Full-Dose Gemcitabine Versus Standard Fractionation Radiotherapy with Concurrent Fluorouracil for Unresectable Pancreatic Cancer: a Multi-Institution Experience.

Rakhra S, Strauss JB, Robertson J, McGinn CJ, Kim T, Huang J, Blake A, Helenowski I, Hayes JP, Mulcahy M, Small W Jr.

J Gastrointest Cancer. 2016 Jun;47(2):196-201. doi: 10.1007/s12029-016-9821-9.

PMID:
27112332
2.

Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.

Small W Jr, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ.

J Clin Oncol. 2008 Feb 20;26(6):942-7. doi: 10.1200/JCO.2007.13.9014.

PMID:
18281668
3.

A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.

Desai SP, El-Rayes BF, Ben-Josef E, Greenson JK, Knol JA, Huang EH, Griffith KA, Philip PA, McGinn CJ, Zalupski MM.

Am J Clin Oncol. 2007 Aug;30(4):340-5.

PMID:
17762432
4.

Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma.

Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):103-10. Epub 2007 Jun 7.

PMID:
17560050
5.

A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.

Talamonti MS, Small W Jr, Mulcahy MF, Wayne JD, Attaluri V, Colletti LM, Zalupski MM, Hoffman JP, Freedman GM, Kinsella TJ, Philip PA, McGinn CJ.

Ann Surg Oncol. 2006 Feb;13(2):150-8. Epub 2006 Jan 19.

6.

Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.

Schneider BJ, Ben-Josef E, McGinn CJ, Chang AE, Colletti LM, Normolle DP, Hejna GF, Lawrence TS, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1325-30. Epub 2005 Jul 1.

PMID:
15993549
7.

Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.

Worden FP, Taylor JM, Biermann JS, Sondak VK, Leu KM, Chugh R, McGinn CJ, Zalupski MM, Baker LH.

J Clin Oncol. 2005 Jan 1;23(1):105-12. Erratum in: J Clin Oncol. 2014 Jan 1;32(1):63. Dosage error in article text. J Clin Oncol. 2006 Sep 1;24(25):4223.

PMID:
15625365
8.

Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.

Allen AM, Zalupski MM, Robertson JM, Eckhauser FE, Simone D, Brown D, Hejna G, Normolle D, Lawrence TS, McGinn CJ.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1461-7.

PMID:
15275733
9.

Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.

Schulz CA, Mehta MP, Badie B, McGinn CJ, Robins HI, Hayes L, Chappell R, Volkman J, Binger K, Arzoomanian R, Simon K, Alberti D, Feierabend C, Tutsch KD, Kunugi KA, Wilding G, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1107-15.

PMID:
15234045
10.

Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.

Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE.

Cancer Res. 2003 Dec 1;63(23):8466-75.

11.

Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.

Muler JH, McGinn CJ, Normolle D, Lawrence T, Brown D, Hejna G, Zalupski MM.

J Clin Oncol. 2004 Jan 15;22(2):238-43. Epub 2003 Dec 9.

PMID:
14665608
12.

Conformal chemoradiation for primary and metastatic liver malignancies.

Dawson LA, McGinn CJ, Lawrence TS.

Semin Surg Oncol. 2003;21(4):249-55. Review.

PMID:
14648782
13.

Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.

Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, Rees R, Sondak VK.

Cancer. 2003 Oct 15;98(8):1716-26.

14.

Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.

Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, Lawrence TS, McGinn CJ.

J Gastrointest Surg. 2003 Sep-Oct;7(6):766-72.

PMID:
13129554
15.

Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.

McGinn CJ, Zalupski MM.

Int J Radiat Oncol Biol Phys. 2003;56(4 Suppl):10-5. Review.

PMID:
12826246
16.

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.

McGinn CJ, Lawrence TS, Zalupski MM.

Cancer. 2002 Aug 15;95(4 Suppl):933-40. Review.

17.

Analysis of radiation-induced liver disease using the Lyman NTCP model.

Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):810-21. Erratum in: Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1422.

PMID:
12095546
18.
19.

Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.

Symon Z, Davis M, McGinn CJ, Zalupski MM, Lawrence TS.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):140-5.

PMID:
12007952
20.

Hormone therapy in men and risk of cardiac allograft rejection.

Schofield RS, Hill JA, McGinn CJ, Aranda JM.

J Heart Lung Transplant. 2002 Apr;21(4):493-5.

PMID:
11927227
21.

Daily targeting of intrahepatic tumors for radiotherapy.

Balter JM, Brock KK, Litzenberg DW, McShan DL, Lawrence TS, Ten Haken R, McGinn CJ, Lam KL, Dawson LA.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):266-71.

PMID:
11777645
22.

The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy.

Dawson LA, Brock KK, Kazanjian S, Fitch D, McGinn CJ, Lawrence TS, Ten Haken RK, Balter J.

Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1410-21.

PMID:
11728702
23.

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS.

J Clin Oncol. 2001 Nov 15;19(22):4202-8.

PMID:
11709563
24.

Recent advances in the use of radiosensitizing nucleosides.

McGinn CJ, Lawrence TS.

Semin Radiat Oncol. 2001 Oct;11(4):270-80. Review.

PMID:
11677652
25.

Combined-modality therapy in pancreatic cancer: current status and future directions.

McGinn CJ, Zalupski MM.

Cancer J. 2001 Jul-Aug;7(4):338-48. Review.

PMID:
11561609
26.

The role of radiation therapy in resectable retroperitoneal sarcomas.

McGinn CJ.

Surg Oncol. 2000 Aug;9(2):61-5. Review. No abstract available.

PMID:
11094324
27.

Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.

McGinn CJ, Pestalozzi BC, Drake JC, Glennon MC, Kunugi K, Otterson G, Allegra CJ, Johnston PG, Kinsella TJ.

Cancer J. 2000 Jul-Aug;6(4):234-42.

PMID:
11038143
28.

Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W, Lawrence TS.

J Clin Oncol. 2000 Jun;18(11):2210-8.

PMID:
10829040
29.
30.

Radiosensitization by gemcitabine.

Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS.

Oncology (Williston Park). 1999 Oct;13(10 Suppl 5):55-60. Review.

31.

Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging.

Balter JM, Lam KL, McGinn CJ, Lawrence TS, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 1998 Jul 1;41(4):939-43.

PMID:
9652861
32.

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.

McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS.

J Clin Oncol. 1998 Jun;16(6):2246-52.

PMID:
9626227
33.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

Robertson JM, McGinn CJ, Walker S, Marx MV, Kessler ML, Ensminger WD, Lawrence TS.

Int J Radiat Oncol Biol Phys. 1997 Dec 1;39(5):1087-92.

PMID:
9392548
34.

Radiosensitizing nucleosides.

McGinn CJ, Shewach DS, Lawrence TS.

J Natl Cancer Inst. 1996 Sep 4;88(17):1193-203. Review.

PMID:
8780628
35.

Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.

McGinn CJ, Kunugi KA, Tutsch KD, Feierabend C, Alberti D, Lindstrom MJ, Wilding G, Arzoomanian RZ, Kinsella TJ.

Clin Cancer Res. 1996 Aug;2(8):1299-305.

36.

Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells.

Pestalozzi BC, McGinn CJ, Kinsella TJ, Drake JC, Glennon MC, Allegra CJ, Johnston PG.

Br J Cancer. 1995 Jun;71(6):1151-7.

37.

The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.

McGinn CJ, Miller EM, Lindstrom MJ, Kunugi KA, Johnston PG, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):851-9.

PMID:
7960987
38.

Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results.

McGinn CJ, Harari PM, Fowler JF, Ford CN, Pyle GM, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):363-9.

PMID:
8407411
39.

The clinical rationale for S-phase radiosensitization in human tumors.

McGinn CJ, Kinsella TJ.

Curr Probl Cancer. 1993 Sep-Oct;17(5):273-321. Review.

PMID:
8281809
40.
41.

Combined modality therapy.

McGinn CJ, Kinsella TJ.

Curr Opin Oncol. 1991 Dec;3(6):1049-54. Review.

PMID:
1843106
42.

Cardiac tamponade resulting from pneumopericardium: case report and implications for the critical care nurse.

Stechmiller J, Seymour SF, McGinn CJ 3rd.

Heart Lung. 1987 Jul;16(4):442-8.

PMID:
3298168
43.

Characteristics of Successful and Probationary Football Officials.

Spurqeon JH, Blair SV, Keith JA, McGinn CJ.

Phys Sportsmed. 1978 Sep;6(9):106-12. doi: 10.1080/00913847.1978.11710761.

PMID:
27437749

Supplemental Content

Loading ...
Support Center